Skip to main content
Clinical Trials/NCT04157829
NCT04157829
Completed
N/A

Evaluation of the Performance and Safety of a Scintillating Lamp Developed to Improve the Reading of Dyslexic Patients

SATT Ouest Valorisation4 sites in 1 country33 target enrollmentDecember 18, 2019
ConditionsDyslexia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dyslexia
Sponsor
SATT Ouest Valorisation
Enrollment
33
Locations
4
Primary Endpoint
Reading performance aloud of a text with french E.L.FE Test
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to evaluate the efficacy and safety of a new medical device on the improvement of reading skills of dyslexic patients.

Detailed Description

Dyslexia is defined as a specific learning disability that is characterized by reading difficulties, in the absence of intellectual disability, neurological or psychiatric disorder, uncorrected sensory disturbance (sight, hearing) or an educational deficiency. Dyslexia appears in the child from the earliest stages of learning in the form of a difficulty in mastering the learning of reading. This disorder is manifested by a generally hesitant reading, slowed down, full of errors, requiring a lot of effort for the child and may impact his reading comprehension. The dyslexia-related deficiency is of variable intensity depending on the individual; it may be accompanied by calculus disorders (dyscalculia), oral language (dysphasia), motor coordination (dyspraxia) or attention disorders with or without hyperactivity. In nearly 40% of cases, a child affected by Dys disorders presents several learning disorders. To date, the causes of dyslexia are not yet clearly established. The wide variety of symptoms and disorders associated with dyslexia does not facilitate the identification of precise neurobiological / psycho cognitive mechanisms. There are therefore several theories: phonological, visual, temporal, cerebellar or proprioceptive auditory processing. Recently, following work published in 2017, an anatomical cause based on Maxwell's spots could also be a cause of dyslexia. The aim of this study is to evaluate a new medical device to compensate this probable anatomical cause.

Registry
clinicaltrials.gov
Start Date
December 18, 2019
End Date
January 8, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
SATT Ouest Valorisation
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Schooled in CE2, CM1 or CM2,
  • French mother tongue,
  • For whom developmental dyslexia has been diagnosed by a health professional who specializes in this learning disorder,
  • Presenting an IQ ≥ 80 and ≤130 according to the WISC-V test performed by a psychologist,
  • For which a written consent was obtained regarding his study participation.

Exclusion Criteria

  • With medical history or presenting a neurological pathology,
  • Presenting a developmental disorder (autism, ADHD, ...),
  • Presenting hearing disorders,
  • Presenting visual disorders,
  • Any other condition that, in the opinion of health professionals, could impair its ability to complete the study or could pose a significant risk.

Outcomes

Primary Outcomes

Reading performance aloud of a text with french E.L.FE Test

Time Frame: 1 day

E.L.FE Test (=Evaluation de la Lecture en FluencE) - "Monsieur Petit" and "Le Géant égoïste" texts : percentile

Secondary Outcomes

  • Patient's satisfaction regarding reading fluency(1 day)
  • Reading performance aloud of isolated words with french BALE Test(1 day)
  • Speech therapist's satisfaction regarding Securirty, Performance and usability of scintilling lamp(1 day)
  • Security: incidence of Adverse Events(1 day)

Study Sites (4)

Loading locations...

Similar Trials